Compare Amylx Pharmaceuticals Inc (AMLX) vs Vistra Corp (VST) Price & Performance

Amylx Pharmaceuticals IncTrade

Vistra CorpTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Vistra Corp — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Vistra Corp trades at $146.04 (market cap $48.64B). The key difference: Vistra Corp is far larger — about 18.4× Amylx Pharmaceuticals Inc's market cap, and Vistra Corp pays a 0.63% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

	AMLX	VST
Market Cap	$2.64B	$48.64B
Sector	Health	Technology
52-Week High	$24.19	$217.92
52-Week Low	$7.82	$134.71
Enterprise Value	$2.39B	$70.58B
Dividend Yield	—	0.63%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMLX

Amylyx shifts focus to endocrine drug avexitide with strong cash runway into 2028 and key trial results in 2026Seeking Alpha · 4 days agoBullish View details →

VST

Vistra Corp. holds steady as earnings rise but sales fall amid rising costs and strategic growth moves.Seeking Alpha · 4 days agoNeutral Vistra misses Q3 earnings estimates due to $472M hedge loss but core operations show strong 30% EBITDA growth.Gordon Thompson · 4 days agoNeutral View details →

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

About Vistra Corp

Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.